Ionis Pharmaceuticals announced the appointment of Ludwig Hantson, Ph.D., a veteran biopharma executive with 30+ years of experience including CEO roles at Alexion and Baxalta, to its Board of Directors effective immediately. The appointment strengthens board expertise as Ionis prepares for multiple commercial launches and accelerated growth.